Aberrant expression of microRNAs in bladder cancer (Q38109811)

29 August 2017

Aberrant expression of microRNAs in bladder cancer (English)

1 reference

29 August 2017

1 reference

2

Naohiko Seki

1 reference

29 August 2017

6

Hideki Enokida

1 reference

29 August 2017

Hirofumi Yoshino

1

1 reference

29 August 2017

Toshihiko Itesako

series ordinal

3

1 reference

29 August 2017

Takeshi Chiyomaru

series ordinal

4

1 reference

29 August 2017

Masayuki Nakagawa

series ordinal

5

1 reference

29 August 2017

language of work or name

English

0 references

publication date

28 May 2013

1 reference

29 August 2017

Nature Reviews Urology

1 reference

29 August 2017

10

1 reference

29 August 2017

396-404

1 reference

29 August 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/nrurol.2013.113

29 August 2017

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Estimates of cancer incidence and mortality in Europe in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Potential new urinary markers in the early detection of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNAs and cancer: past, present, and potential future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Accurate molecular classification of kidney cancer subtypes using microRNA signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Origins and Mechanisms of miRNAs and siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Identification of mammalian microRNA host genes and transcription units

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA genes are transcribed by RNA polymerase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA biogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Cooperative control of tumor suppressor genes by a network of oncogenic microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA control of signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

miRNA signature of schwannomas: possible role(s) of "tumor suppressor" miRNAs in benign tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Clinical outcome prediction by microRNAs in human cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Characterization of microRNAs expression profiling in one group of Chinese urothelial cell carcinoma identified by Solexa sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA expression signatures of bladder cancer revealed by deep sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Distinct microRNA alterations characterize high- and low-grade bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Up-regulation of microRNA in bladder tumor tissue is not common.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Identification of novel microRNA targets based on microRNA signatures in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA-143 as a tumor suppressor for bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Micro-RNA profiling in kidney and bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

The functional significance of miR-1 and miR-133a in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

A microRNA polycistron as a potential human oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Novel ZEB1 expression in bladder tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

microRNA-203 suppresses bladder cancer development by repressing bcl-w expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Molecular requirements for epithelial-mesenchymal transition during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

TGF-beta-induced epithelial to mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

The functional significance of microRNA-145 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Diagnostic and prognostic microRNAs in stage II colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Downregulation of microRNAs-143 and -145 in B-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Gene networks and microRNAs implicated in aggressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Clustering and conservation patterns of human microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

miR-15a and miR-16-1 in cancer: discovery, function and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

mir-17-92, a cluster of miRNAs in the midst of the cancer network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Identification of non-coding RNAs embracing microRNA-143/145 cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA and cancer--focus on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Modulation of microRNA processing by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

p53 represses c-Myc through induction of the tumor suppressor miR-145

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Transcriptional regulation and transformation by Myc proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Complementation by wild-type p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNAs as putative mediators of treatment response in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.113

Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23712207

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23712207

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

miR-145-mediated suppression of cell growth, invasion and metastasis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23712207

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRUROL.2013.113

1 reference

Dimensions Publication ID

29 August 2017

0 references

1 reference